{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:46:15Z","timestamp":1762458375695},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.taap.2003.08.013","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T13:04:02Z","timestamp":1069333442000},"page":"10-23","source":"Crossref","is-referenced-by-count":107,"title":["Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats"],"prefix":"10.1016","volume":"194","author":[{"given":"William H","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery W","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy F","family":"Loughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana A","family":"Stoffregen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori A","family":"Mixson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis C","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad E","family":"Raab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan X","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George R","family":"Lankas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clay B","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2003.08.013_BIB1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0003-9861(92)90511-T","article-title":"Distribution and redox state of ubiquinones in rat and human tissues","volume":"295","author":"Aberg","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.taap.2003.08.013_BIB2","doi-asserted-by":"crossref","first-page":"10J","DOI":"10.1016\/0002-9149(88)90002-1","article-title":"Discovery, biochemistry and biology of lovastatin","volume":"62","author":"Alberts","year":"1988","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.taap.2003.08.013_BIB3","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1073\/pnas.77.7.3957","article-title":"Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent","volume":"77","author":"Alberts","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2003.08.013_BIB4","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Anonymous","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2003.08.013_BIB5","first-page":"258","article-title":"Statin myopathies: pathophysiologic and clinical perspectives","volume":"24","author":"Baker","year":"2001","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.taap.2003.08.013_BIB6","first-page":"218","article-title":"Biochemical and clinical consequences of inhibiting coenzyme Q10 biosynthesis by lipid-lowering HMG-CoA reductase inhibitors (statins): a critical overview","volume":"15","author":"Bliznakov","year":"1998","journal-title":"Adv. Ther."},{"key":"10.1016\/j.taap.2003.08.013_BIB7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0304-4157(82)90009-0","article-title":"Arrangement of proteins in the mitochondrial inner membrane","volume":"694","author":"Capaldi","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2003.08.013_BIB8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0891-5849(00)00307-5","article-title":"Regulation of ubiquinone metabolism","volume":"29","author":"Dallner","year":"2000","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.taap.2003.08.013_BIB9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0925-4439(95)00028-3","article-title":"Biochemical, physiological and medical aspects of ubiquinone function","volume":"1271","author":"Ernster","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2003.08.013_BIB10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0091-679X(01)65005-2","article-title":"Assessing functional integrity of mitochondria in vitro and in vivo","volume":"65","author":"Esposti","year":"2001","journal-title":"Meth. Cell Biol."},{"key":"10.1016\/j.taap.2003.08.013_BIB11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00041433-200208000-00009","article-title":"The myotoxicity of statins","volume":"13","author":"Evans","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.taap.2003.08.013_BIB12","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1016\/S0021-9258(18)43600-9","article-title":"Synthesis of delta 2-isopentenyl tRNA from mevalonate in cultured human fibroblasts","volume":"255","author":"Faust","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2003.08.013_BIB13","doi-asserted-by":"crossref","first-page":"8931","DOI":"10.1073\/pnas.87.22.8931","article-title":"Lovastatin decreases coenzyme Q levels in humans","volume":"87","author":"Folkers","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2003.08.013_BIB14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/j.1552-4604.1993.tb03948.x","article-title":"Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study","volume":"33","author":"Ghirlanda","year":"1993","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2003.08.013_BIB15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0005-2760(94)90200-3","article-title":"Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins","volume":"1212","author":"Grunler","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2003.08.013_BIB16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.278.4.313","article-title":"Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials","volume":"278","author":"Hebert","year":"1997","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.taap.2003.08.013_BIB17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0009-9236(95)90266-X","article-title":"Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans","volume":"57","author":"Laaksonen","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2003.08.013_BIB18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0002-9149(97)89180-1","article-title":"The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle","volume":"77","author":"Laaksonen","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.taap.2003.08.013_BIB19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-5793(01)03172-6","article-title":"A critical appraisal of the mitochondrial coenzyme Q pool","volume":"509","author":"Lenaz","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2003.08.013_BIB20","first-page":"139","article-title":"Assay of mitochondrial ATP synthesis in animal cells","volume":"65","author":"Manfredi","year":"2001","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.taap.2003.08.013_BIB21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/taap.1998.8491","article-title":"Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study","volume":"152","author":"Nakahara","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2003.08.013_BIB22","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1021\/jo01309a006","article-title":"Regio- and stereoselective synthesis of coenzymes Qn (n = 2 \u2013 10), vitamin K, and related polyprenylquinones","volume":"45","author":"Naruta","year":"1980","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.taap.2003.08.013_BIB23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-4347(00)84487-4","article-title":"High-performance liquid chromatography of coenzyme Q-related compounds and its application to biological materials","volume":"342","author":"Okamoto","year":"1985","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.taap.2003.08.013_BIB24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0083-6729(08)60431-8","article-title":"Biosynthesis of ubiquinone","volume":"40","author":"Olson","year":"1983","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.taap.2003.08.013_BIB25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0011-393X(98)85064-9","article-title":"A comparison of the effects of lovastatin and pravastatin on ubiquinone tissue levels in rats","volume":"59","author":"Rousseau","year":"1998","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.taap.2003.08.013_BIB26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2003.08.013_BIB27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0003-9861(91)90259-L","article-title":"Possible involvement of 3-hydroxymethylglutaryl-CoA reductase in determining the side-chain length of ubiquinone in rat heart","volume":"284","author":"Shimizu","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.taap.2003.08.013_BIB28","first-page":"1225","article-title":"HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies","volume":"257","author":"Smith","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2003.08.013_BIB29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0076-6879(69)13005-0","article-title":"Citrate synthase","volume":"13","author":"Srere","year":"1969","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.taap.2003.08.013_BIB30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0005-2728(82)90301-2","article-title":"Studies on reduced and oxidized coenzyme Q (ubiquinones): II. The determination of oxidation\u2013reduction levels of coenzyme Q in mitochondria, microsomes and plasma by high-performance liquid chromatography","volume":"679","author":"Takada","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2003.08.013_BIB31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0014-5793(92)81425-L","article-title":"Half-life of ubiquinone-9 in rat tissues","volume":"313","author":"Thelin","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2003.08.013_BIB32","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.taap.2003.08.013_BIB33","doi-asserted-by":"crossref","first-page":"11J","DOI":"10.1016\/S0002-9149(98)00424-X","article-title":"Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor","volume":"82","author":"von-Keutz","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.taap.2003.08.013_BIB34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00005072-199309000-00012","article-title":"Experimental lovastatin myopathy","volume":"52","author":"Waclawik","year":"1993","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.taap.2003.08.013_BIB35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0076-6879(67)10048-7","article-title":"Cytochrome oxidase from beef heart mitochondria","volume":"10","author":"Wharton","year":"1967","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.taap.2003.08.013_BIB36","first-page":"69","article-title":"Simvastatin-induced myopathy in a patient treated for hypercholesterolemia. Morphological aspects","volume":"48","author":"Wicher-Muniak","year":"1997","journal-title":"Pol. J. Pathol."},{"key":"10.1016\/j.taap.2003.08.013_BIB37","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1073\/pnas.87.22.8928","article-title":"Lovastatin decreases coenzyme Q levels in rats","volume":"87","author":"Willis","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X03004186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X03004186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T03:25:01Z","timestamp":1623554701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X03004186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0041008X03004186"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2003.08.013","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}